IDXX vs IQV — Key Metrics

Metric IDXX (IDEXX LABORATORIES INC) IQV (IQVIA HOLDINGS INC)
Price698.47257.84
Market Cap55.03 Billion42.49 Billion
P/E (TTM)46.8131.03
P/B (Quarterly)28.316.719
P/S (TTM)11.82.45
Net Profit Margin (TTM)25.48.1
Gross Margin (TTM)62.733.1
ROE (TTM)71.221.8
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

IDEXX LABORATORIES INC
vs
 
IQVIA HOLDINGS INC
 
IDEXX LABORATORIES INC
vs
 
IQVIA HOLDINGS INC
Performance Comparison
AI Model Recommendation
IDXX · IDEXX LABORATORIES INC

Greatly Underperform

-98
UnderperformOutperform
IQV · IQVIA HOLDINGS INC

Underperform

-2
UnderperformOutperform
Recommendation Summary

Stock IDXX is projected to greatly underperform the market, stock IQV is projected to underperform the market. Upfront Recommendation: IQV.

Financial Metrics
Prices delayed ~15 min
IDXX Metrics IQV
$698.47 Price $257.84
— Market Capitalization —
46.81 Price to Earnings Ratio 31.03
11.8 Price to Sales 2.45
42.65 Price to FCF Ratio 20.44
18.82 Price to Gross Profit 7.42
36.69 Price to Current Assets 6.59

IDXX vs IQV at a glance

Idexx Laboratories INC (IDXX) and Iqvia Holdings INC (IQV) are both Diagnostics & Research companies in the Healthcare sector. IDXX is the larger, at $55.0 billion in market value against $42.5 billion for IQV, about 1.3 times the size.

On trailing-twelve-month figures, IDXX trades at 46.8 times trailing earnings and IQV at 31.0; net profit margins are 25.4% and 8.1%.

The Upfront Investment model currently rates IDXX Greatly Underperform and IQV Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.